Invivyd logo

Invivyd Share Price Today

(NASDAQ: IVVD)

Invivyd share price is $1.06 & ₹92.19 as on 6 Mar 2025, 2.30 'hrs' IST

$1.06

0.01

(0.95%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Invivyd share price in Dollar and Rupees. Guide to invest in Invivyd stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Invivyd, along with analyst recommendations, forecasts, and comprehensive financials.

Invivyd share price movements

  • Today's Low: $1.01
    Today's High: $1.11

    Day's Volatility :9.06%

  • 52 Weeks Low: $0.35
    52 Weeks High: $4.74

    52 Weeks Volatility :92.52%

Invivyd (IVVD) Returns

PeriodInvivyd IncIndex (Russel 2000)
3 Months
83.95%
0.0%
6 Months
23.33%
0.0%
1 Year
-72.51%
0.0%
3 Years
-79.08%
-11.6%

Invivyd (IVVD) Key Statistics

in dollars & INR

Previous Close
$1.05
Open
$1.15
Today's High
$1.1106
Today's Low
$1.01
Market Capitalization
$125.6M
Today's Volume
$606.2K
52 Week High
$4.74
52 Week Low
$0.3546
Revenue TTM
$11.6M
EBITDA
$-234.5M
Earnings Per Share (EPS)
$-2.15
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-136.59%

How to invest in Invivyd Stock (IVVD) from India?

It is very easy for Indian residents to invest directly in Invivyd from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Invivyd stock in both Indian Rupees (INR) and US Dollars (USD). Search for Invivyd or IVVD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Invivyd or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Invivyd shares which would translate to 0.820 fractional shares of Invivyd as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Invivyd, in just a few clicks!

Returns in Invivyd (IVVD) for Indian investors in Rupees

The Invivyd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Invivyd investment value today

Current value as on today

₹32,711

Returns

₹67,289

(-67.29%)

Returns from Invivyd Stock

₹72,251 (-72.25%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Invivyd (IVVD)

2430.0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Invivyd Shares from India has grown by 2430.0% over the past 30 days, indicating increased transactional activity.

750%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Invivyd Stock from India on INDmoney has increased by 750% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Invivyd

  • Maverick Capital Ltd

    9.84%

  • Deep Track Capital, LP

    8.94%

  • M28 Capital Management LP

    7.73%

  • FMR Inc

    4.83%

  • BlackRock Inc

    3.97%

  • Vanguard Group Inc

    3.63%

Analyst Recommendation on Invivyd

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Invivyd(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
7
6
Hold
2
3
4
Sell
0
0
0

Analyst Forecast on Invivyd Stock (IVVD)

What analysts predicted

Upside of 528.93%

Target:

$6.67

Current:

$1.06

Insights on Invivyd Stock (Ticker Symbol: IVVD)

  • Price Movement

    In the last 7 days, IVVD stock has moved down by -14.6%
  • IVVD vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 134.6%
  • IVVD vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 126.8%
  • Price to Sales

    ForIVVD every $1 of sales, investors are willing to pay $10.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Invivyd Technicals Summary

Sell

Neutral

Buy

Invivyd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Invivyd (IVVD) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Invivyd Inc logo
-0.94%
23.33%
-72.51%
-79.08%
-94.97%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Invivyd Inc logo
NA
NA
NA
-1.38
-1.37
-0.67
NA
0.7
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Invivyd Inc logo
Buy
$125.6M
-94.97%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Invivyd

Invivyd, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering. Its pipeline includes PEMGRADA (pemivibart) injection, a half-life extended investigational monoclonal antibody (mAb) for the prevention of COVID-19 in adults and adolescents; VYD2311, an mAb candidate which is in preclinical studies for the prevention or treatment for COVID-19; and adintrvimab, that is in phase 3 clinical trials for the prevention or treatment of COVID-19. The company also has discovery stage candidates for the prevention of seasonal influenza and COVID-19. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.
Organization
Invivyd
Employees
94
CEO
Dr. Robert D. Allen Ph.D.
Industry
Healthcare

Management People of Invivyd

NameTitle
Dr. Robert D. Allen Ph.D.
Chief Scientific Officer
Ms. Jill Andersen J.D.
Chief Legal Officer & Corporate Secretary
Mr. William E. Duke Jr., M.B.A.
CFO & Principal Executive Officer
Scott Young
Senior Vice President of Investor Relations & Corporate Communications
Ms. Julie Green M.B.A.
Chief Human Resources Officer
Dr. Mark A. Wingertzahn Ph.D.
Senior Vice President of Clinical Development & Medical Affairs
Mr. Timothy Lee
Chief Commercial Officer

Important FAQs about investing in IVVD Stock from India :

What is Invivyd share price today?

Invivyd share price today stands at $1.06, Open: $1.15 ; Previous Close: $1.05 ; High: $1.11 ; Low: $1.01 ; 52 Week High: $4.74 ; 52 Week Low: $0.35.

The stock opens at $1.15, after a previous close of $1.05. The stock reached a daily high of $1.11 and a low of $1.01, with a 52-week high of $4.74 and a 52-week low of $0.35.

Can Indians buy Invivyd shares?

Yes, Indians can invest in the Invivyd (IVVD) from India.

With INDmoney, you can buy Invivyd at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Invivyd at zero transaction cost.

How can I buy Invivyd shares from India?

It is very easy to buy Invivyd from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Invivyd (IVVD) be purchased?

Yes, you can buy fractional shares of Invivyd with INDmoney app.

What are the documents required to start investing in Invivyd stocks?

To start investing in Invivyd, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Invivyd Stock (IVVD)?

Today’s highest price of Invivyd (IVVD) is $1.11.

Today’s lowest price of Invivyd (IVVD) is $1.01.

What is today's market capitalisation of Invivyd?

Today's market capitalisation of Invivyd IVVD is 125.6M

What is the 52 Week High and Low Range of Invivyd Stock (IVVD)?

  • 52 Week High

    $4.74

  • 52 Week Low

    $0.35

What are the historical returns of Invivyd (IVVD)?

  • 1 Month Returns

    -0.94%

  • 3 Months Returns

    23.33%

  • 1 Year Returns

    -72.51%

  • 5 Years Returns

    -94.97%

Who is the Chief Executive Officer (CEO) of Invivyd ?

Dr. Robert D. Allen Ph.D. is the current Chief Executive Officer (CEO) of Invivyd.